New collaborative research center based at University of California, Berkeley, plans to develop platform approaches that can be easily modified to develop gene-editing medicines for hundreds of devastating illnesses Innovative model aims to dramatically reduce preclinical and clinical development time and expense for investigational rare disease therapies that currently struggle to attract funding Nobel laureate Doudna and team to partner with Danaher to oversee center's translational and clinical researc ...

WASHINGTON, Jan. 8, 2024 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) (the "Company") announced that its President and Chief Executive Officer, Rainer M. Blair, will comment tomorrow on the Company's fourth quarter 2023 performance in a presentation at the J.P. Morgan Healthcare Conference at 2:15 p.m. ET. For the fourth quarter 2023, estimated revenues are anticipated to decrease in the low-double digit percent range year-over-year. Estimated non-GAAP core revenue for the fourth quarter of 2023 is expe ...

The latest trading session saw Danaher (DHR) ending at $230.81, denoting a -1.7% adjustment from its last day's close. This change lagged the S&P 500's 0.8% loss on the day. Meanwhile, the Dow experienced a drop of 0.76%, and the technology-dominated Nasdaq saw a decrease of 1.18%.Shares of the industrial and medical device maker have appreciated by 7% over the course of the past month, outperforming the Conglomerates sector's gain of 5.58% and the S&P 500's gain of 3.4%.The upcoming earnings release of Dan ...

WASHINGTON, Jan. 2, 2024 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the J.P. Morgan Healthcare Conference in San Francisco, California on Tuesday, January 9, 2024 at 2:15 p.m. ET. The event will be simultaneously webcast on www.danaher.com. ABOUT DANAHERDanaher is a leading global life sciences and diagnostics innovator, committed to accelerating the power of science and technology to improve human health. Our ...

Sundry Photography Introduction As a long-term-oriented investor, I'm always searching for companies that also orient themselves to the long term. There are many ways you can measure that, and yes, it is somewhat subjective. But I believe few companies do it better and more decisively than Danaher (NYSE:DHR). Data by YCharts And while a chart of the share price doesn't always tell the whole story, in the case of Danaher, I believe it's a strong indicator of the quality of this business and its managemen ...

Antagain Danaher (NYSE:DHR) has been a core portfolio holding for me throughout this year and is my SWAN stock pick for 2024. SWAN stands for Sleep Well At Night, a business with a low-risk profile without much worry for investors. I bought my first share in 2020 and have since waited for the opportunity to buy at attractive prices, which has materialized in 2023. I built up a sizable position (#1 in my portfolio at 10%) and believe that Danaher is set to outperform the market again. Let's get into my r ...

Danaher Corporation (NYSE:DHR) 6th Annual Evercore ISI HealthCONx Conference November 29, 2023 3:00 PM ET Company Participants Rainer Blair - CEO Conference Call Participants Vijay Kumar - Evercore ISI Vijay Kumar Thanks, everyone, for joining us this afternoon. A pleasure to have with us, Danaher. We have CEO, Rainer Blair, with us. Rainer, thanks for spending the time with us this afternoon. Rainer Blair Pleasure to be here, Vijay. Thanks for having us. Question-and-Answer Session Q - Vijay Kumar There's ...

Danaher Corporation (NYSE:DHR) Q3 2023 Earnings Conference Call October 24, 2023 8:00 AM ET Company Participants John Bedford - Vice President of Investor Relations Rainer Blair - President and Chief Executive Officer Matt McGrew - Executive Vice President and Chief Financial Officer Conference Call Participants Dan Brennan - TD Cowen Vijay Kumar - Evercore ISI Scott Davis - Melius Research Michael Ryskin - Bank of America Puneet Souda - Leerink Partners Rachel Vatnsdal - JPMorgan Operator Good morning. My ...

Danaher Corporation Third Quarter 2023 Earnings Release Forward ...

Danaher Corporation (NYSE:DHR) Q2 2023 Earnings Conference Call July 25, 2023 8:00 AM ET Company Participants John Bedford - VP, IR Rainer Blair - President and CEO Matt McGrew - EVP and CFO Conference Call Participants Michael Ryskin - Bank of America Vijay Kumar - Evercore ISI Scott Davis - Melius Research Dan Brennan - TD Cowen Puneet Souda - Leerink Partners Rachel Vatnsdal - JPMorgan Luke Sergott - Barclays Operator My name is Ashley, and I'll be your facilitator this morning. At this time, I would lik ...